Dalbagni, G.

Genetic alterations in bladder cancer

Dalbagni, G., Presti, J., Fair, W. R., Reuter, V., & Cordon-Cardo, C. (1993) · The Lancet

Bladder and Urothelial Cancer TreatmentsUrinary and Genital Oncology Studies

Cited by 238

Somatic mutation of fibroblast growth factor receptor‐3 ( FGFR3 ) defines a distinct morphological subtype of high‐grade urothelial carcinoma

Al‐Ahmadie, H. A., Iyer, G., Janakiraman, M., Lin, O., Heguy, A., Tickoo, S. K., Fine, S. W., Gopalan, A., Chen, Y., Balar, A., et al. (2011) · The Journal of Pathology

Bladder and Urothelial Cancer TreatmentsFibroblast Growth Factor Research

Cited by 88